Smoking and interstitial lung diseases

George Margaritopoulos(Royal Brompton Hospital), Eirini Vasarmidi(University Hospital of Heraklion), Joseph Jacob(Royal Brompton Hospital), Athol U. Wells(Royal Brompton Hospital), Κατερίνα Αντωνίου(University Hospital of Heraklion)
European Respiratory Review
August 31, 2015
Cited by 106Open Access
Full Text

Abstract

For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of smoking in the development of interstitial lung diseases (ILDs). Indeed, there are three diseases, namely respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia and pulmonary Langerhans cell histiocytosis, that are currently considered aetiologically linked to smoking and a few others which are more likely to develop in smokers. Here, we aim to focus on the most recent findings regarding the role of smoking in the pathogenesis and clinical behaviour of ILDs.


Related Papers

No related papers found

Powered by citation graph analysis